Inventor · disambiguated record
Richard Soll
Also filed as: PLAYER MARK · SOLL RICHARD · SOLL RICHARD M
68 granted patents·15 pending applications·2,124 citations·filing 1989–2021
99Inventor score
Files withDIMENSIONAL PHARM INC34MERCK SHARP & DOHME9AMERICAN HOME PROD8TARGEGEN INC7ACURX PHARMACEUTICALS LLC4
Top patents by PatentIndex Score
83 records- 0199US5463564ASystem and method of automatically generating chemical compounds with desired propertiesDIMENSIONAL PHARM INC·Filed 1994·Granted Oct 31, 1995·389 cites·64 claims
- 0297US7528143B2Bi-aryl meta-pyrimidine inhibitors of kinasesTARGEGEN INC·Filed 2006·Granted May 5, 2009·220 cites·44 claims
- 0397US6434490B1Method of generating chemical compounds having desired propertiesDIMENSIONAL PHARM INC·Filed 1998·Granted Aug 13, 2002·91 cites·5 claims
- 0496US8871759B2Inhibitors of hepatitis C virus replicationCOBURN CRAIG A·Filed 2010·Granted Oct 28, 2014·60 cites·20 claims
- 0596US6421612B1System, method and computer program product for identifying chemical compounds having desired propertiesDIMENSIONAL PHARM INC·Filed 1997·Granted Jul 16, 2002·159 cites·42 claims
- 0696US5684711ASystem, method, and computer program for at least partially automatically generating chemical compounds having desired propertiesDIMENSIONAL PHARM INC·Filed 1996·Granted Nov 4, 1997·153 cites·54 claims
- 0796US5574656ASystem and method of automatically generating chemical compounds with desired propertiesDIMENSIONAL PHARM INC·Filed 1995·Granted Nov 12, 1996·182 cites·2 claims
- 0895US7825246B2Bi-aryl meta-pyrimidine inhibitors of kinasesTARGEGEN INC·Filed 2007·Granted Nov 2, 2010·40 cites·9 claims
- 0995US5901069ASystem, method, and computer program product for at least partially automatically generating chemical compounds with desired properties from a list of potential chemical compounds to synthesizeDIMENSIONAL PHARM INC·Filed 1997·Granted May 4, 1999·123 cites·18 claims
- 1094US8138199B2Use of bi-aryl meta-pyrimidine inhibitors of kinasesNORONHA GLENN·Filed 2008·Granted Mar 20, 2012·45 cites·31 claims
- 1192US8604042B2Bi-aryl meta-pyrimidine inhibitors of kinasesNORONHA GLENN·Filed 2010·Granted Dec 10, 2013·29 cites·5 claims
- 1291US9364482B2Substituted benzofuran compounds and methods of use thereof for the treatment of viral diseasesMERCK SHARP & DOHME·Filed 2014·Granted Jun 14, 2016·8 cites·15 claims
- 1391US9090661B2Inhibitors of hepatitis C virus replicationMERCK SHARP & DOHME·Filed 2014·Granted Jul 28, 2015·18 cites·16 claims
- 1488US9265773B2Tetracyclic heterocycle compounds and methods of use thereof for the treatment of viral diseasesMCCOMAS CASEY C·Filed 2012·Granted Feb 23, 2016·8 cites·15 claims
- 1586US5330989AHeterocycles substituted with biphenyl-3-cyclobutene-1,2-dione derivativesAMERICAN HOME PROD·Filed 1992·Granted Jul 19, 1994·31 cites·6 claims
- 1685US8030487B22-amino—5-substituted pyrimidine inhibitorsTARGEGEN INC·Filed 2007·Granted Oct 4, 2011·10 cites·34 claims
- 1785US7456176B2Benzotriazine inhibitors of kinasesTARGEGEN INC·Filed 2005·Granted Nov 25, 2008·11 cites·34 claims
- 1885US6326492B1Heterocyclic protease inhibitorsDIMENSIONAL PHARM INC·Filed 2000·Granted Dec 4, 2001·25 cites·41 claims
- 1984US6420397B1Heteroaryl protease inhibitors and diagnostic imaging agentsDIMENSIONAL PHARM INC·Filed 2000·Granted Jul 16, 2002·15 cites·35 claims
- 2083US5612378ABis-arylsulfonylaminobenzamide derivatives and the use thereof as factor Xa inhibitorsDIMENSIONAL PHARM INC·Filed 1995·Granted Mar 18, 1997·41 cites·10 claims
- 2182US9242998B2Tetracyclic heterocycle compounds and methods of use thereof for the treatment of hepatitis CHE SHUWEN·Filed 2014·Granted Jan 26, 2016·8 cites·17 claims
- 2282US6706765B2Aminoguanidines and alkoxyguanidines as protease inhibitorsDIMENSIONAL PHARM INC·Filed 2003·Granted Mar 16, 2004·12 cites·34 claims
- 2382US6506784B1Use of 1,3-substituted pyrazol-5-yl sulfonates as pesticidesDIMENSIONAL PHARM INC·Filed 2000·Granted Jan 14, 2003·14 cites·17 claims
- 2482US5741819AArylsulfonylaminobenzene derivatives and the use thereof as factor Xa inhibitorsDIMENSIONAL PHARM INC·Filed 1995·Granted Apr 21, 1998·57 cites·27 claims
- 2581US6638931B1Aminoguanidines and alkoxyguanidines as protease inhibitorsDIMENSIONAL PHARM INC·Filed 2000·Granted Oct 28, 2003·11 cites·39 claims
- 2681US5792769AGuanidino protease inhibitors3-DIMENSIONAL PHARM INC·Filed 1996·Granted Aug 11, 1998·34 cites·49 claims
- 2780US9573939B2Substituted benzofuran compounds and methods of use thereof for the treatment of viral diseasesMCCOMAS CASEY C·Filed 2012·Granted Feb 21, 2017·6 cites·6 claims
- 2880US7030110B2Cyclic oxyguanidine pyrazinones as protease inhibitorsORTHO MCNEIL PHARM INC·Filed 2002·Granted Apr 18, 2006·8 cites·28 claims
- 2980US6730783B2Process for preparing aminoguanidines and alkoxyguanidines as protease inhibitorsDIMENSIONAL PHARM INC·Filed 2003·Granted May 4, 2004·9 cites·39 claims
- 3080US6518266B11- Aryl-3-thioalkyl pyrazoles, the synthesis thereof and the use thereof as insecticidesDIMENSIONAL PHARMACEUTICALS 3·Filed 2000·Granted Feb 11, 2003·17 cites·41 claims
- 3180US6476016B2Cyclic oxyguanidine pyrazinones as protease inhibitorsDIMENSIONAL PHARM INC·Filed 2001·Granted Nov 5, 2002·12 cites·25 claims
- 3280US6344466B2Benzamide and sulfonamide substitued aminoguanidines and alkoxyguanidines as protease inhibitorsDIMENSIONAL PHARM INC·Filed 2001·Granted Feb 5, 2002·13 cites·42 claims
- 3379US6518310B2Aminoguanidines and alkoxyguanidines as protease inhibitorsDIMENSIONAL PHARM INC·Filed 2001·Granted Feb 11, 2003·9 cites·36 claims
- 3479US6281206B1Amidino protease inhibitorsDIMENSIONAL PHARM INC·Filed 2000·Granted Aug 28, 2001·8 cites·28 claims
- 3577US5498775APolyanionic benzylglycosides as inhibitors of smooth muscle cell proliferationAMERICAN HOME PROD·Filed 1994·Granted Mar 12, 1996·41 cites·23 claims
- 3676US6635637B2Cyclic oxyguanidine protease inhibitorsDIMENSIONAL PHARM INC·Filed 2001·Granted Oct 21, 2003·9 cites·50 claims
- 3775US5891909AAmidinohydrazones as protease inhibitorsDIMENSIONAL PHARM INC·Filed 1997·Granted Apr 6, 1999·39 cites·76 claims
- 3874US8691825B2Inhibitors of AKT activityCHEN QI·Filed 2010·Granted Apr 8, 2014·3 cites·4 claims
- 3974US6414020B2Amidino protease inhibitorsDIMENSIONAL PHARM INC·Filed 2001·Granted Jul 2, 2002·4 cites·27 claims
- 4074US6409988B1Radiolabeled 1-aryl pyrazoles, the synthesis thereof and the use thereof as pest GABA receptor ligandsDIMENSIONAL PHARM INC·Filed 2000·Granted Jun 25, 2002·4 cites·16 claims
- 4173US6225302B1Amidino protease inhibitorsDIMENSIONAL PHARM INC·Filed 2000·Granted May 1, 2001·4 cites·26 claims
- 4272US6890930B1QuinazolinonesDIMENSIONAL PHARM INC·Filed 2000·Granted May 10, 2005·8 cites·64 claims
- 4370US4908378ABenzopyran derivatives and antihypertensive use thereofAMERICAN HOME PROD·Filed 1989·Granted Mar 13, 1990·8 cites·8 claims
- 4469US10723741B1DNA polymerase IIIC inhibitors and use thereofACURX PHARMACEUTICALS LLC·Filed 2019·Granted Jul 28, 2020·0 cites·11 claims
- 4569US2022112195A1DNA Polymerase IIIC Inhibitors and Use ThereofACURX PHARMACEUTICALS LLC·Filed 2021·Application pending·0 cites
- 4668US11001592B2DNA polymerase IIIC inhibitors and use thereofACURX PHARMACEUTICALS LLC·Filed 2020·Granted May 11, 2021·0 cites·17 claims
- 4767US10836772B2DNA polymerase IIIC inhibitors and use thereofACURX PHARMACEUTICALS LLC·Filed 2020·Granted Nov 17, 2020·0 cites·6 claims
- 4867US9549917B2Heterocyclic-substituted benzofuran derivatives and methods of use thereof for the treatment of viral diseasesMCCOMAS CASEY C·Filed 2012·Granted Jan 24, 2017·1 cites·14 claims
- 4967US6235778B1Aminoguanidines and alkoxyguanidines as protease inhibitorsDIMENSIONAL PHARM INC·Filed 1997·Granted May 22, 2001·17 cites·42 claims
- 5066US6545033B1Fused 1-(2,6-dichloro-4-trifluoromethylphenyl)-pyrazoles, the synthesis thereof and the use thereof as pesticidesDIMENSIONAL PHARM INC·Filed 2000·Granted Apr 8, 2003·3 cites·21 claims
Showing the top 50 of 83 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when Richard Soll files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →